If you liked this article you might like

'Mad Money' Lightning Round: I Can't Recommend Gilead
Jim Cramer's 'Mad Money' Recap: Markets Make This Economy, Not the Fed
Gilead Sciences Shares Slide on Leerink Price Target Cut
Gilead (GILD) Price Target Cut Amid Weak Outlook for HIV Drug Sales